
BSV and tokenizing IP: A new paradigm for creators
Getting your Trinity Audio player ready...
In an era where creators struggle to protect and monetize their intellectual property (IP), BSV emerges as a transformative platform for tokenizing IP assets. By leveraging its scalable blockchain, low-cost transactions, and immutable data storage, BSV enables artists, writers, inventors, and creators to secure, manage, and monetize their work without relying on costly intermediaries.
From fractional ownership of patents to micropayments for digital content, BSV offers a new paradigm for IP management that empowers creators and redefines the creative economy. This article explores how BSV addresses longstanding IP challenges and its potential to reshape the creator landscape.
The IP crisis in the digital age
Creators face significant hurdles in protecting and profiting from their IP. Traditional systems like copyright offices and patent registries are slow, expensive, and often inaccessible to independent artists or small-scale inventors. Digital platforms, while democratizing distribution, frequently exploit creators through unfavorable revenue splits or fail to prevent piracy. For instance, musicians earn fractions of a cent per stream on platforms like Spotify, while authors battle unauthorized e-book distribution. This is why we need a system where creators control their own IP.
Tokenization—the process of representing assets as digital tokens on a blockchain—offers a solution, but most blockchains lack the scalability or affordability to support widespread IP applications. BSV, with its unbounded block size and high transaction throughput, fills this gap, enabling creators to tokenize everything from songs to scientific patents in a secure, cost-effective manner.
BSV's technical advantages for IP tokenization
BSV's blockchain is uniquely suited for IP management. Its ability to process 1,000,000 transactions per second (TPS), as demonstrated by the Teranode upgrade, supports global-scale tokenization without network congestion. Transaction fees, often below $0.00011, make it feasible to issue and trade tokens for small-value assets, such as a single poem or a 3D-printed design. The blockchain's immutable ledger ensures that tokenized IP records—such as proof of authorship or licensing agreements—are tamper-proof and verifiable.
BSV's smart contract capabilities enable complex IP management workflows. For example, a musician could tokenize a song, embedding royalty splits that automatically distribute micropayments to collaborators each time it's streamed. Fractional ownership is another key feature: a patent for a new technology could be tokenized into 1,000 shares, allowing inventors to raise capital by selling stakes to investors. BSV's timestamping functionality provides a definitive record of creation dates, helping creators prove originality in disputes. Think of it as unhackable timestamping. Niche applications: Empowering creators
BSV's IP tokenization shines in niche use cases that traditional systems overlook. Independent authors can tokenize e-books, offering readers exclusive access or limited-edition digital copies as non-fungible tokens (NFTs). Unlike Ethereum-based NFTs, which incur high gas fees, BSV's low costs make this viable for small creators. Visual artists can tokenize digital artworks, embedding resale royalty clauses to earn a percentage of future sales, addressing the 'starving artist' problem.
Inventors, particularly in open-source or collaborative fields, benefit from BSV's fractional ownership model. A team developing a new biotech patent could tokenize it, allowing global investors to fund research in exchange for equity-like tokens. This democratizes innovation, enabling small-scale inventors to compete with corporate giants. Additionally, BSV's data storage capabilities allow creators to embed metadata—such as licensing terms or creative commons agreements—directly into tokens, streamlining IP management.
The future: A creator-centric economy
BSV's potential to transform IP management extends beyond individual creators. Applications are building BSV-based tools that integrate tokenization into creative workflows, from music production to patent filing. These tools could disrupt centralized platforms, giving creators direct access to global markets and simultaneously removing the middleman.
Challenges remain, including regulatory hurdles and the need for user-friendly interfaces. However, BSV's regulation-friendly design, built to comply with legal frameworks, positions it to gain institutional adoption. As creators demand fairer systems, BSV's scalable, transparent approach could become the standard for IP tokenization, fostering a creator-centric economy.
Conclusion
BSV's ability to tokenize IP offers creators unprecedented control over their work. Its scalable blockchain, low fees, and smart contract functionality enable niche applications like fractional patents, royalty micropayments, and timestamped authorship records. By bypassing traditional intermediaries, BSV empowers artists, authors, and inventors to monetize their IP securely and transparently. As the creative economy evolves, BSV stands poised to redefine how intellectual property is managed, proving that blockchain can deliver tangible benefits for creators worldwide.
Watch: Small casual payments transforms content creation business
title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen="">
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BBC News
3 hours ago
- BBC News
Trump's tariffs 'not going away', top adviser says
US President Donald Trump is not planning to extend the pause to his sweeping global tariffs, Commerce Secretary Howard Lutnick president's plan - where countries face between 11% to more than 100% tariffs on goods brought into the US - was announced in April. But the majority of the tariffs were paused by Trump for 90 days in the wake of stock market with Fox News, Lutnick said he expects the President to stand firm when that 90 day pause expires at the start of July.A key trade deal would be with China, who US Treasury Secretary Scott Bessent said has "not been a reliable partner" and claimed it was holding back products in the global supply chain. The president's top trade advisers presented a united front in their appearances on separate US morning television programmes on remained steadfast on the tariff agenda, which has faced ongoing challenges in the nation's court system."Tariffs are not going away," Lutnick said in response to the court added that the US "could sign lots of deals now" but the Trump administration is working to "make them better". "You're going to see over the next couple of weeks, really, first class deals for the American worker," he said.. And on the expiration of the 90 day pause, Lutnick said: "I think that's the deadline, and the President's just going to determine what rates people have if they can't get a deal done". When the pause expires, in theory it would enact sweeping tariffs on countries across the globe. Imports from about 60 trading partners that the White House has described as the "worst offenders", including the European Union, Vietnam, South Africa and more, will face higher rates. Trump has described these taxes as payback for unfair trade tariffs has Trump announced and why?US pauses higher tariffs for most countries after market havoc, but hits China harderOn Friday, Trump announced the US will double its current tariff rate on steel and aluminium imports from 25% to 50%, beginning on with most of the announced tariffs, Trump said the move would help boost local steel industry, while reducing US reliance on China. US steel manufacturing has decreased in recent years and countries like China, India and Japan have become the world's biggest producers. The steel tariffs come as many hold their breath waiting for further announcements. from the Trump administration. Trump's tariff policies have upended global trade and cracks have formed - or widened - among relationships between the US and other countries, including some of its closest partners. World watches for news of US-China trade deal The levies have worsened relations between China and the US, the two largest global economies - and launched the countries into a tit-for-tat trade a trade truce struck in May at Geneva, the US lowered tariffs imposed on goods from China from 145% to 30%. China's retaliatory tariffs on US goods dropped from 125% to 10%.But a larger trade deal between the countries has not been established. On Sunday, Treasury Secretary Bessent told CBS News, the BBC's US news partner, details of the trade will be "ironed out" once Chinese President Xi Jinping and Trump speak, but he did not say exactly when that conversation is expected. "What China is doing is they are holding back products that are essential for the industrial supply chains of India, of Europe. And that is not what a reliable partner does," Bessent Treasury Secretary claimed China could be withholding some products because of a "glitch", or he said it could be "intentional" - but the administration would not know for sure until a call with both countries happened. On Friday, China urged the US to "immediately correct its erroneous actions, cease discriminatory restrictions against China and jointly uphold the consensus reached at the high-level talks in Geneva".White House National Economic Council Director Kevin Hassett told ABC News on Sunday that Trump and Xi are expected to talk this week, and said "both sides have expressed a willingness to talk". "The bottom line is that we've got to be ready in case things don't happen the way we want," Hassett said of the expected China talks. "Because if we have cannons without cannonballs, then we can't fight a war.""We have to have a steel industry that's ready for American defence," he said.


Geeky Gadgets
8 hours ago
- Geeky Gadgets
Deepseek R1-0528: The Open Source AI Model That Could Topple Big Tech Giants
What if one model could dismantle the dominance of AI giants like OpenAI and Google? That's exactly what some are saying about Deepseek R1-0528, the open source disruptor that's sending shockwaves through the artificial intelligence industry. With performance that rivals proprietary titans like GPT-4 and Gemini 2.5 Pro—at a fraction of the cost—Deepseek isn't just another player in the game; it's rewriting the rules entirely. But this isn't just about cheaper AI. It's about a deeper shift in power, accessibility, and the very future of how we innovate. Could this be the moment where open source finally topples the closed gates of Big Tech? Wes Roth explores how Deepseek R1-0528 is reshaping the AI landscape and what it means for you. From its new cost efficiency to the ethical dilemmas it raises, this model is more than just a technological achievement—it's a statement. You'll discover the methods behind its performance, the growing divide between open source and proprietary AI, and the geopolitical tensions fueling this revolution. Whether you're a tech enthusiast, a business leader, or just curious about the future of AI, this story has implications that reach far beyond the tech world. After all, when the foundations of an industry shake, everyone feels the tremors. Deepseek's Disruptive Impact Performance That Matches Industry Leaders Deepseek R1-0528 has demonstrated its ability to compete with some of the most advanced proprietary AI models available today. Benchmark tests reveal that it outperforms Google's Gemini 2.5 Pro in specific tasks while maintaining parity with OpenAI's GPT-4 (03) in others. However, what truly sets Deepseek apart is its cost efficiency. By offering significantly lower API costs, it makes high-performance AI accessible to a broader audience, including small businesses, independent researchers, and startups. This affordability has the potential to provide widespread access to AI adoption, allowing organizations with limited budgets to use innovative technology. For you, this means access to powerful AI tools without the financial barriers often associated with proprietary systems. Open source vs. Proprietary AI: A Growing Divide The rise of Deepseek R1-0528 highlights the increasing divide between open source and proprietary AI models. Open source solutions like Deepseek challenge the business models of closed-source companies by delivering similar capabilities at a fraction of the cost. This shift could lead to a more equitable distribution of AI technology, allowing smaller players to compete with industry giants. However, it also raises concerns about the sustainability of proprietary research and development. Proprietary models often rely on substantial funding to push the boundaries of innovation, and the growing popularity of open source alternatives could disrupt this ecosystem. For you, the choice between open source and proprietary AI may come down to balancing cost, performance, and long-term support. Deepseek R1-0528 Just Broke the Entire AI Industry Watch this video on YouTube. Take a look at other insightful guides from our broad collection that might capture your interest in Deepseek. How Deepseek Achieves Its Performance The methods behind Deepseek R1-0528's impressive performance have sparked significant interest and speculation. Experts suggest that the model may have employed knowledge distillation, a technique where synthetic outputs from proprietary models like Gemini are used to train new models. This approach enables open source models to replicate the performance of their proprietary counterparts without requiring direct access to their datasets. Additionally, bioinformatics tools have been used to analyze AI outputs, providing insights into model lineage and training strategies. These innovative methods demonstrate how open source models can achieve high performance while operating within resource constraints, offering a blueprint for future development in the field. Global AI Competition: The U.S. and China Face Off The release of Deepseek R1-0528 underscores the intensifying competition between the United States and China in AI development. Historically, the U.S. has been a leader in software innovation, but China's growing focus on open source AI and its advanced hardware manufacturing capabilities could shift the balance of power. For instance, China's expertise in semiconductor production may provide it with an edge in deploying AI systems at scale. Meanwhile, U.S. policymakers are exploring strategies such as R&D tax incentives to maintain their competitive advantage. For you, this rivalry could influence the availability, affordability, and direction of AI technologies in the years to come, shaping the tools and platforms you rely on. Ethical and Strategic Challenges The rise of open source AI models like Deepseek R1-0528 brings both opportunities and challenges. On one hand, open source AI aligns with the goal of providing widespread access to access to advanced technologies, making them available to a wider audience. On the other hand, it introduces risks related to AI safety and misuse. For example, the accessibility of powerful AI tools could lead to unintended consequences, such as their use in malicious applications. Governments and private organizations in both the U.S. and China are under scrutiny for their roles in AI development. Critics question whether concerns about safety and regulation are genuine or driven by geopolitical motives, adding complexity to the ethical debate. For you, understanding these challenges is essential to navigating the evolving AI landscape responsibly. The Future of AI Innovation As global competition in AI intensifies, the stakes for innovation and collaboration continue to rise. Open source models like Deepseek R1-0528 have the potential to redefine the industry by making advanced AI capabilities more accessible and affordable. For researchers, developers, and businesses, this represents an opportunity to innovate without being constrained by proprietary systems. However, the broader implications for national security, economic policy, and ethical standards remain uncertain. The balance between fostering innovation and addressing potential risks will play a critical role in shaping the future of AI. For you, staying informed about these developments will be key to using the opportunities and addressing the challenges that lie ahead. Media Credit: Wes Roth Filed Under: AI, Top News Latest Geeky Gadgets Deals Disclosure: Some of our articles include affiliate links. If you buy something through one of these links, Geeky Gadgets may earn an affiliate commission. Learn about our Disclosure Policy.


The Independent
9 hours ago
- The Independent
‘Pivotal' new breast cancer drug can help stop tumours early
A new drug has been found to halt the growth of certain breast cancer tumours, offering hope to patients and delaying the need for chemotherapy - with one professor describing the drug as 'a pivotal moment in breast cancer care'. The Serena-6 trial revealed that camizestrant effectively stops cancer cells from using hormones to fuel their growth. According to scientists, this is the first global study demonstrating that early detection of cancer resistance through blood tests can significantly benefit patients. The study focused on patients with hormone-positive, HER2-negative breast cancer, which accounts for approximately 70 per cent of all cases. Results indicated that patients treated with camizestrant experienced a 56 per cent reduction in cancer progression compared to those receiving standard therapies. Doctors employed a straightforward blood test to identify changes in the cancer's DNA, which signal the potential failure of current treatments. Upon detecting these signs, some patients were administered camizestrant, while others continued with their standard treatment. Those on camizestrant had their cancer stay the same and not get worse for much longer, 16 months on average, compared with about nine months for the others. The drug was safe for most patients but 1 per cent stopped taking it because of side effects. More than 3,000 patients from 23 countries took part in the study, which was funded by AstraZeneca and co-led by researchers at The Institute of Cancer Research in London. Co-principal investigator Professor Nick Turner, group leader in molecular oncology at The Institute of Cancer Research, London, said the drug is 'a pivotal moment in breast cancer care'. Professor Kristian Helin, chief executive of The Institute of Cancer Research said: 'The results of the Serena-6 trial represent more than a clinical milestone, they represent a transformational shift in how we approach precision medicine.' About 55,000 women are diagnosed with breast cancer in the UK every year and 11,500 will die from the disease, The Institute of Cancer Research said. The Serena-6 trial results were to be presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday. Dr Catherine Elliott, director of research at Cancer Research UK, said: 'This study is a clear example of how blood tests are starting to transform cancer treatment. 'By tracking tiny traces of tumour DNA in the blood, researchers were able to spot early signs of treatment resistance and switch therapies before cancer had a chance to grow. 'It shows how circulating tumour DNA, or ctDNA, could help doctors make smarter, more timely treatment decisions. 'This approach could become an important part of how we personalise care for people with advanced breast cancer.'